EnteroMedics

homesitemapcontact us

   search

 

   
   
   
   
 

Top News

 
 

Archives 2017

 
 

Archives 2016

 
 

Archives 2015

 
 

Archives 2014

 
 

Archives 2013

 
 

Archives 2012

 
 

Archives 2011

 
 

Archives 2010

 
 

Archives 2009

 
 

Publications

 
 

Press Kit

 
 

Media Contact

 

For press inquiries, please contact:

Media Contact:
Eliza Schleifstein
212-600-1902
eliza@argotpartners.com

 

Press Releases



All Releases
View Summary EnteroMedics Named One of Fast Company's Top Ten Most Innovative Companies in Biotech for 2016
Feb 16, 2016
PDF 14.5 KB Add to Briefcase
View Summary EnteroMedics to Host Fourth Quarter 2015 Financial Results and Commercialization Update Conference Call
Feb 3, 2016
PDF 14.4 KB Add to Briefcase
View Summary Winthrop-University Hospital Becomes First Employer in the U.S. to Cover Innovative Obesity Treatment vBloc Therapy
Feb 2, 2016
PDF 16.5 KB Add to Briefcase
View Summary EnteroMedics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Jan 22, 2016
PDF 13.7 KB Add to Briefcase
View Summary EnteroMedics Announces Closing of $11 Million Tranche from Previously-Announced Convertible Notes Offering
Jan 13, 2016
PDF 16.1 KB Add to Briefcase
View Summary EnteroMedics Announces Senior Level Appointments, New Commercial Operations Organization Structure
Jan 6, 2016
PDF 15.9 KB Add to Briefcase
View Summary EnteroMedics Announces Publication in SOARD of ASMBS Position Statement on Vagal Blocking Therapy for Obesity
Jan 5, 2016
PDF 15.1 KB Add to Briefcase
View Summary EnteroMedics Announces 1-for-15 Reverse Split
Dec 23, 2015
PDF 15.2 KB Add to Briefcase
View Summary EnteroMedics to Host Year-end Company Update Conference Call
Dec 8, 2015
PDF 12.9 KB Add to Briefcase
View Summary EnteroMedics to Present at the Canaccord Genuity Medical Technology & Diagnostics Forum
Nov 11, 2015
PDF 14.1 KB Add to Briefcase
View Summary EnteroMedics Reports Third Quarter 2015 Financial Results and Commercial Progress Update
Nov 9, 2015
PDF 22.9 KB Add to Briefcase
View Summary EnteroMedics Announces $25.0 million Registered Direct Offering of Convertible Notes
Nov 5, 2015
PDF 15.6 KB Add to Briefcase
View Summary vBloc® Therapy Data Demonstrate Two Year Maintenance of Clinically Significant Weight Loss and Sustained Improvements in Obesity Related Risk Factors
Nov 4, 2015
PDF 19.9 KB Add to Briefcase
View Summary EnteroMedics Announces Dan Gladney Appointed President and Chief Executive Officer
Nov 2, 2015
PDF 15.5 KB Add to Briefcase
View Summary Sustained Weight Loss, Ongoing Reduction of Cardiovascular Risk Factors and Continued Glycemic Control at Two Years: Data from EnteroMedics' vBloc DM2 Study Published in the Journal of Obesity Surgery
Oct 27, 2015
PDF 16.7 KB Add to Briefcase
View Summary vBloc® Neurometabolic Therapy Demonstrates 34% Excess Weight Loss in ReCharge Study Patients with Moderate Obesity and a Comorbidity
Sep 1, 2015
PDF 18.3 KB Add to Briefcase
View Summary Mark B. Knudson, Ph.D., EnteroMedics Founder, Chairman, President and Chief Executive Officer, to Retire at the End of 2015
Aug 25, 2015
PDF 15.4 KB Add to Briefcase
View Summary EnteroMedics Reports Second Quarter 2015 Financial Results
Aug 6, 2015
PDF 18.8 KB Add to Briefcase
View Summary EnteroMedics to Present at the Canaccord Genuity 35th Annual Growth Conference
Aug 5, 2015
PDF 13.7 KB Add to Briefcase
View Summary EnteroMedics Announces Appointment of Lori C. McDougal to the Board of Directors
Aug 3, 2015
PDF 13.5 KB Add to Briefcase
Showing 41-60 of 206 Page: 1 2 3 4 5 6 7 ... 11  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase